SCHEMBL8335482

SCHEMBL8335482

CCOc1ccc(CC(CN(CC(=O)OC(C)(C)C)CC(Cc2ccc(OCC)cc2)N(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)N(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)cc1

nearest known ligand 0.40

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ACACB O00763 14/20 0.40
ALOX5 P09917 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
PAX8 Q06710 1/20 0.38
ATM Q13315 1/20 0.38
NR1D1 P20393 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL92706 0.94 ACACB (0.38) ACACBALOX5SMN1; SMN2LMNAHTT
SCHEMBL15044629 0.94 ACACB (0.38) ACACBALOX5SMN1; SMN2LMNAHTT
SCHEMBL8668171 0.91 ACACB (0.37) ACACBALOX5NR1D1
SCHEMBL21852438 0.91 MAOB (0.38) ACACBALOX5SMN1; SMN2ALDH1A1
SCHEMBL8387440 0.89 ACACB (0.40) ACACBALOX5SMN1; SMN2KDM4EALDH1A1
SCHEMBL15044628 0.88 ACACB (0.34) ACACBALOX5SMN1; SMN2LMNAHTT
SCHEMBL22304893 0.87 LTA4H (0.37) ACACBALOX5ALDH1A1
SCHEMBL7516386 0.85 PTPN1 (0.41) ACACBRAB9ANR1D1
SCHEMBL21852439 0.85 MAOB (0.35) ACACBALOX5SMN1; SMN2ALDH1A1
SCHEMBL8099592 0.84 SMN1; SMN2 (0.40) SMN1; SMN2NR1D1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5885548-A Multiply substituted DTPA derivatives and their metal complexes, and their metal complexes, pharmaceutical agents that contain these complexes, their use in diagnosis and therapy, as well as process for the production of pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-23 US disclosed
US-5853699-A Use of tetra azacycle complexes as x-ray diagnostic agents for the liver and gallbladder SCHERING AKTIENGESELLSCHAFT (DE) 1998-12-29 US disclosed
EP-0794939-A1 NOVEL MULTIPLE-SUBSTITUENT DTPA DERIVATIVES AND METAL COMPLEXES THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPLEXES, THEIR USE IN DIAGNOSIS AND THERAPY, METHODS OF PREPARING THE COMPLEXING AGENTS AND COMPLEXES AND METHODS OF PREPARING THE PHARMACEUTICAL COMPOSITIONS SCHERING AKTIENGESELLSCHAFT (DE) 1997-09-17 EP disclosed
WO-1996016929-A1 NOVEL MULTIPLE-SUBSTITUENT DTPA DERIVATIVES AND METAL COMPLEXES THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPLEXES, THEIR USE IN DIAGNOSIS AND THERAPY, METHODS OF PREPARING THE COMPLEXING AGENTS AND COMPLEXES AND METHODS OF PREPARING THE PHARMACEUTICAL COMPOSITIONS SCHERING AKTIENGESELLSCHAFT (DE) 1996-06-06 WO disclosed